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Abstract
We investigated the effect of carriage of Staphylococcus aureus in the later stages of
pregnancy on levels of antibody specific to the S. aureus toxins, staphylococcal
enterotoxin B (SEB), staphylococcal enterotoxin C (SEC) and toxic shock
syndrome toxin-1 (TSST-1), in cord blood and breast milk and also explored the
relationship between levels of antibody in antenatal serum and cord blood.
Nasopharyngeal swabs and stool samples were collected on two occasions, from
96 women, during the last 6 weeks of pregnancy. Samples were cultured and
S. aureus isolates were identified. Antenatal and cord blood samples from the same
women and their infants were analysed for IgG antibody to SEB, SEC and TSST-1
by enzyme-linked immunosorbent assay. Breast milk samples were analysed for
IgA antibody to the same toxins. We found that S. aureus carriage in pregnancy is
common and exposure to a toxin-producing isolate boosts immunity. Over 89% of
women and infants have some protective antibody to the toxins, and antitoxin IgG
levels are higher in cord blood samples compared with antenatal samples. Levels of
cord blood IgG and breast milk IgA specific for the staphylococcal toxins vary.
Some infants lack protection and could be at risk of toxin-induced disease.
Introduction
It has been suggested that toxins produced by common
nasopharyngeal bacteria can act in synergy to cause sudden
death in infants with low levels of circulating immunoglo-
bulins (Morris et al., 1987). There is considerable support
for this hypothesis from theoretical, experimental and
epidemiological studies (Morris, 1999), which show that
the hypothesis can explain the key epidemiological features
of sudden infant death syndrome (SIDS), including the age
distribution, the winter excess of cases and the association
with prone sleeping and exposure to tobacco smoke.
A candidate organism for a pathogenic role in SIDS is the
bacterium Staphylococcus aureus. Staphylococcus aureus has
been identified as the most common colonizer of the
nasopharynx in the early months of life when SIDS inci-
dence reaches a peak (Blackwell et al., 1999; Harrison et al.,
1999a). Pyrogenic toxins produced by S. aureus have been
implicated in SIDS cases (Newbould et al., 1989; Telford
et al., 1989; Malam et al., 1992; Murrell et al., 1993; Zorgani
et al., 1999), with one study detecting the toxins in the
tissues of over 50% of SIDS cases from three different
countries (Zorgani et al., 1999).
A study to determine the presence of toxin-specific
antibodies in sera found that a significantly smaller propor-
tion of sera from SIDS cases tested positive for IgG to a
number of bacterial toxins, including staphylococcal enter-
otoxin B (SEB), than an age-matched comparison group
(Siarakas et al., 1999). Our previous research has revealed
that specific maternal IgG to staphylococcal enterotoxin C
(SEC) and toxic shock syndrome toxin (TSST-1) is mark-
edly variable in cord blood samples, and in some cases, the
samples tested negative (Harrison et al., 2004).
Transplacental transfer of IgG is upregulated in the last
trimester of pregnancy (Holt & Jones, 2000) and factors that
influence the production of specific maternal IgG during
this period should be reflected in cord blood levels. Anti-
bodies contained in breast milk are also a response to a
woman’s exposure to specific antigens. The aims of this
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of S. aureus in the later stages of pregnancy influenced the
levels of antibody specific to the S. aureus toxins (SEB, SEC
and TSST-1) in cord blood and breast milk and to explore
the relationship between the levels of antibody in antenatal
blood and cord blood.
Materials and methods
Population studied
Pregnant women were recruited to the study at antenatal
classes. The study had ethical approval from the Preston,
Chorley and South Ribble Local Research Ethics Committee
and informed consent was obtained from the women.
Sample collection and preparation
Cord blood samples were collected by the midwives. The
samples were separated and the serum was stored at
 70 1C. Blood samples taken during the second trimester,
as part of the normal antenatal procedure, were processed
and stored in the same manner as the cord blood samples.
Women were visited at home on two occasions during the
last 6 weeks of pregnancy. Before each visit, participants
collected a stool sample in a sterile container and stored it in
a refrigerator. A nasopharyngeal swab was taken at each visit.
Isolation and identification of S. aureus
Staphylococcus aureus was isolated and identified from
nasopharyngeal swabs using standard clinical laboratory
methods. Stool samples were diluted serially in 10-fold steps
in peptone water and cultured aerobically on Staphylococcus
medium no 110 (Oxoid) at 37 1C for 2 days. Colonies of
different morphology were enumerated and subcultured on
blood agar. Standard methods were used to identify
S. aureus isolates. All S. aureus isolates were stored at  70 1C
for further tests.
Detection of IgG to staphylococcal pyrogenic
toxins in antenatal and cord blood
Serum samples were examined for IgG antibody to SEB, SEC
and TSST-1 by an enzyme-linked immunosorbent assay
(ELISA). A modification of the protocol of Al Madani et al.
(1999) was used. Test and control wells were coated with
100mL of SEB, SEC or TSST-1 at 1 mgmL1 in carbonate
buffer (Sigma). Standard wells were coated with 100 mL of
serial dilutions of human IgG (Sigma); concentrations
ranged from 5 to 10 000 ngmL1. Plates were incubated
overnight at 4 1C. The wells were then emptied and washed
four times with washing buffer [0.05% (v/v) Tween-20 in
phosphate-buffered saline (PBST)]. The plates were blocked
for 1 h at 37 1C with a buffer containing 5% (w/v) skimmed-
milk powder in PBST. Plates were washed four times. Serum
samples were diluted in buffer [2.5% (w/v) skimmed-milk
powder in PBST] and 100 mL was loaded into each test well.
The same buffer (100mL) was added to standard and control
wells. Plates were then incubated for 1 h at 37 1C. After four
washes, 100 mL of anti-human IgG, conjugated to horse-
radish peroxidase (HRP) (Sigma) diluted in buffer [2.5%
(w/v) skimmed-milk powder in PBST], was added to the test
and standard wells. HRP-labelled sheep anti-SEB (100mL),
HRP-labelled sheep anti-SEC (100mL) or HRP-labelled
sheep anti-TSST-1, diluted 1 in 300 in buffer [2.5% (w/v)
skimmed-milk powder in PBST], was added to the appro-
priate control wells. The plates were incubated for 1 h at
37 1C. After three washes, 100mL of the substrate 3,30,5,50-
tetramethylbenzidine (TMB) (Sigma) was added to each
well. The substrate contained 1mg TMB in 10mL of 0.05M
phosphate–citrate buffer (pH 5.0) and was activated im-
mediately before use by adding 2 mL of 30% (v/v) H2O2. The
reaction was stopped after 15min by the addition of 100mL
2M H2SO4 and the absorbance was read at 450 nm with a
plate reader (Organon Teknika).
Detection of IgA to staphylococcal pyrogenic
toxins in breast milk
A modification of the protocol of Gordon et al. (1999) was
used. Test and control wells of microtitre plates were coated
with 100 mL of SEB, SEC or TSST-1 at 1 mgmL1 in
carbonate buffer. Standard wells were coated with 100 mL of
serial dilutions of a standard human IgA derived from
colostrum (Sigma); concentrations ranged from 5 to
10 000 ngmL1. Plates were incubated overnight at 4 1C
and then washed four times. The plates were blocked for
1 h at 37 1C. After three washes, 100mL samples of breast
milk diluted in blocking buffer were loaded into the appro-
priate test wells. Blocking buffer (100mL) was added to
standard and control wells. Plates were incubated for 1 h at
37 1C. After four washes, 100 mL of HRP-labelled goat anti-
human IgA (Calbiochem) diluted in blocking buffer was
added to the test and standard wells and 100 mL of HRP-
labelled sheep anti-SEB, HRP-labelled sheep anti-SEC or
HRP-labelled sheep anti-TSST-1, diluted 1 in 300 in block-
ing buffer, was added to the appropriate control wells. The
plates were incubated at 37 1C for 1 h. The experiment then
continued as described previously.
Detection of toxin production by S. aureus
isolates
Staphylococcus aureus isolates were cultured using the cello-
phane over agar technique (Newbould et al., 1989) and the
resulting supernatant samples were analysed by ELISA. Test
and control wells were coated with 100mL of anti-SEB, anti-
SEC or anti-TSST-1 (Toxin Technology), diluted 1 : 1000 in
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at 4 1C and then emptied and washed four times with
washing buffer. The plates were blocked with blocking buffer
containing 2.5% (v/v) fish gelatin in PBST. Plates were
washed four times. Supernatant samples and controls were
diluted in PBSQ2 and 100mL was loaded into each test well.
Controls included purified SEB, purified SEC, purified
TSST-1 (Toxin Technology, Sarasota, FL) and supernatant
prepared from S. aureus isolates previously tested for the
production of SEB, SEC and TSST-1 (Colindale Public
Health Laboratory). Plates were then incubated for 1 h at
37 1C. After four washes, 100mL of the corresponding
biotinylated antitoxin (Toxin Technology) diluted 1 in 2000
in blocking buffer was added to the test and control wells.
The plates were incubated for 1 h at 37 1C. After four washes,
100 mL of extravidin peroxidase (Sigma) diluted 1 : 2000 was
added to each well and plates were incubated for 30min at
37 1C. The experiment then continued as described pre-
viously.
Statistical analyses
Results were analysed using SPSS software (version 13.0).
Nonparametric tests were used for data that were not
normally distributed. These data were not normalized by
log transformation because many nil values were detected.
Spearman’s correlation coefficient was used to assess the
association between levels of antibody in antenatal and cord
blood samples. Antitoxin levels were compared between
antenatal and cord blood samples using the the Wilcoxon
matched samples test. w2 Test, Mann–Whitney U-test and
Kruskal–Wallis test were used to assess antitoxin levels in
relation to other variables. Comparison of data is presented
in Figs 1, 3 and 4 as box and whisker plots. The box
represents the 25th–75th percentiles, and the median is
represented by the line within the box. The whiskers
represent the 5th–95th percentiles and the circles and stars
depict outliers for each group.
Results
Population characteristics
Ninety-six pregnant women were enrolled into the study.
The mean gestation period was 281 days (range 257–296,
SD 9.5). The average maternal age at birth was 31 years
(range 18–42, SD 4.4). There was no significant associa-
tion between length of gestation and maternal age.
Detection of IgG to staphylococcal pyrogenic
toxins in blood samples
Ninety-two antenatal blood samples were available to test
for the presence of IgG to SEB, SEC and TSST-1. The
median level of antibody to SEB was 3799 ngmL1 (mean:
6204 ngmL1; range: 0–35 588 ngmL1; SD 6846). Anti-
body levels to SEC ranged from 0 to 21 499 ngmL1
(median: 5045 ngmL1; mean: 6248 ngmL1; SD 5858)
and those for TSST-1 ranged from 0 to 16 412 ngmL1
(median: 943 ngmL1; mean: 1674 ngmL1; SD 2333).
Eight women (8.7%) had no detectable IgG to SEB, six
(6.5%) had no detectable IgG to SEC and 10 (10.9%) had no
detectable IgG to TSST-1.
Ninety-six cord blood samples were collected and tested
for the presence of IgG to SEB, SEC and TSST-1. The
median level of antibody to SEB was 4608 ngmL1 (mean:
8987 ngmL1; range: 0–46 605 ngmL1; SD 11 190). Anti-
body levels to SEC ranged from 0 to 53 886 ngmL1
(median: 4001 ngmL1; mean: 8970 ngmL1; SD 10 861)
and those for TSST-1 ranged from 0 to 14 154 ngmL1
(median: 1170 ngmL1; mean: 2512 ngmL1; SD 3084).
Seven samples (7.3%) had no detectable IgG to SEB, three
(3.1%) had no detectable IgG to SEC and seven (7.3%) had
no detectable IgG to TSST-1. There was no significant
association between maternal age and antibody levels or
between length of gestation and antibody levels. However,
84% of pregnant women over the age of 30, but only 68% of
pregnant women under the age of 30 had antibody to all
three toxins (difference not significant).
Male infants (n= 51) had significantly lower levels of cord
blood IgG to SEC than female infants (n= 45) (P= 0.05,
Mann–Whitney U-test, Fig. 1). For anti-SEC IgG, the mean
level in males was 7440 ngmL1 and in females the mean
level was 10 705 ngmL1. No significant differences were
found between male and female infants for cord blood IgG
levels to SEB or TSST-1.
Antenatal anti-SEB IgG correlated positively with cord
blood anti-SEB IgG (r= 0.815, Po 0.01). Antenatal anti-
SEC IgG correlated positively with cord blood anti-SEC IgG












































































Fig. 1. Levels of anti-SEC IgG in the cord blood of male and female
infants.
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correlated positively with cord blood anti-TSST-1 IgG
(r= 0.721, Po 0.01). Paired sample tests showed that
specific IgG levels to each of the toxins were significantly
greater in the cord blood samples than in the antenatal
blood samples (Po 0.01).
Detection of IgA to staphylococcal pyrogenic
toxins in breast milk
Breast milk samples were collected from 83 women in the
first 7 days following the birth of their baby. The median
level of antibody to SEB was 201 ngmL1 (mean:
423 ngmL1; range: 0–10 000 ngmL1; SD 1135). Anti-
body levels to SEC ranged from 0 to 5370 ngmL1 (median:
154 ngmL1; mean: 402 ngmL1; SD 787) and those for
TSST-1 ranged from 0 to 3050 ngmL1 (median: 0 ngmL1;
mean: 146 ngmL1; SD 472).
Breast milk anti-SEB IgA showed a significant positive
correlation with cord blood anti-SEB IgG (r= 0.233,
Po 0.05). Breast milk anti-SEC-1 IgA correlated positively
with cord blood anti-SEC-1 IgG (r= 0.321, Po 0.01).
Breast milk anti-TSST-1 IgA showed no significant associa-
tion with cord blood anti-TSST-1 IgG.
Carriage of S. aureus in pregnant women
Of the 96 women, 29 (30.2%) were colonized with S. aureus.
Sixty-seven women (69.8%) had negative nasopharyngeal
and stool cultures, four (4.2%) had positive nasopharyngeal
and stool cultures, 16 (16.7%) were nasopharyngeal carriers
only and nine (9.4%) were stool carriers only. Of the women
with positive nasopharyngeal cultures, 50% were colonized
with S. aureus on both sampling occasions. Of the women
with positive stool cultures, 23% were colonized with
S. aureus on both sampling occasions. The mean S. aureus
count per gram of faeces was 1.99 104, (range:
1.2 103–1.2 105; SD 3.1 104).
Colonization with S. aureus was not significantly asso-
ciated with IgG levels to the S. aureus toxins in antenatal or
cord blood or with IgA levels to the S. aureus toxins in
breast milk. There was no relationship between carriage of
S. aureus and maternal age.
Detection of toxin production by S. aureus
isolates
Staphylococcus aureus isolates were tested for the production
of SEB, SEC and TSST-1. Thirteen per cent of isolates
produced SEB, 13% produced SEC and 24% produced
TSST-1. Some isolates produced more than one toxin.
Women colonized with an isolate producing the toxin
SEB were significantly more likely to have greater levels of
anti-SEB IgG in cord blood compared with women not
carrying an SEB-producing isolate (Po 0.05, Mann–Whit-
ney U-test, Fig. 3). This trend was also found for SEC and
TSST-1 but was not statistically significant.
Breast milk anti-SEC IgA levels were significantly greater
if the mother was colonized with a S. aureus isolate produ-
cing SEC (Po 0.05). Mothers colonized with a TSST-1-
producing isolate had greater levels of anti-TSST-1 IgA
(P= 0.001, Fig. 4). This association was also seen for SEB/
anti-SEB IgA but was not statistically significant (P= 0.078).
Discussion
An assumption of the common bacterial toxins hypothesis is
that healthy infants will mount an effective immunological
response when first exposed to specific toxin antigens, or
they will succumb to their effects if they lack sufficient


































































































Fig. 3. Colonization with SEB-producing Staphylococcus aureus and its
association with cord blood anti-SEB IgG levels.
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immunity is conferred on the infant by placental transfer of
IgG from the mother. Thus, the mother’s IgG profile will
determine the infant’s immunological status at birth.
In this study, analysis of antenatal serum detected IgG to
SEB, SEC and TSST-1 in 92%, 93.5% and 89.1% of samples,
respectively. Analysis of the cord sera detected IgG to SEB,
SEC and TSST in 92.7%, 96.9% and 92.7% of samples,
respectively. These proportions are very similar to those
found in healthy adults from Europe and the United States
(Notermans et al., 1983; Vergeront et al., 1983; Loch et al.,
1986; Parsonnet et al., 2005). There are a small proportion of
infants who are born with no detectable passive immunity to
one or more of the toxins and could be at risk of death if, on
exposure to the toxins, they fail to mount an effective
immune response. A study by Siarakas et al. (1999), com-
paring serum antibody levels to SEB between SIDS cases and
an age-matched comparison group of infants, found that a
significantly smaller proportion of the SIDS cases had
specific IgG and IgM. This implies that the SIDS infants
had low levels of specific maternal IgG, or that on exposure
to the toxin, antibody had been consumed and the infant
had no time to mount an effective immune response.
Factors associated with an increased risk of SIDS are also
associated with the induction of bacterial pyrogenic toxins
(Harrison et al., 2004).
Cord blood samples from male infants born to women in
this study had significantly lower levels of anti-SEC IgG
compared with female infants (Fig. 1). Male infants are at an
increased risk of SIDS (Leach et al., 1999). Afro-American
women are reported to have significantly lower serum levels
of IgG to TSST-1 (Parsonnet et al., 2005) compared with
white American women and the SIDS rate for infants born
to Afro-American women is twice that of white American
women (Mathews & MacDorman, 2007). However,
Japanese women also have lower levels of IgG to TSST-1
(Takahashi et al., 2006) than European or white American
women, but the SIDS rate in Japan is low (0.4/1000) (Fujita,
2002). Traditionally, Japanese infants have been placed to
sleep in the supine position. At the end of 1998, only
20–30% of African American infants were placed to sleep
supine. Sleeping supine greatly reduces the risk of SIDS
(Leach et al., 1999). Infants sleeping supine are less likely to
be exposed to the factors that induce production of pyro-
genic toxins in the upper respiratory tract (Blackwell et al.,
1999; Harrison et al., 1999b; Molony et al., 1999).
Transplacental transfer of IgG is upregulated in the last
trimester of pregnancy (Holt & Jones, 2000), and in a full-
term gestation, IgG concentration is usually higher in the
cord serum than in the maternal serum (Wilmott-Pitcher
et al., 1980). Essery et al. (1999), analysing sera collected
from pregnant women between 30 and 40 weeks gestation,
found that levels of SEC- and TSST-1-specific IgG decreased
with weeks of gestation but levels of SEB-specific IgG
showed an increase. In our previous study (Harrison et al.,
2004), we reported that antibody levels to SEC and TSST-1
in cord blood samples showed a trend to increase with
length of gestation. In this study, paired sample tests
revealed that antibody levels to each of the toxins were
significantly higher in cord sera than in the antenatal sera.
The findings indicate active transport across the placenta,
which might explain the decrease in the serum levels of some
antitoxins in the latter stages of pregnancy reported by
Essery et al. (1999).
Antenatal anti-SEC IgG showed a significant positive
correlation with cord blood anti-SEC IgG (Fig. 2) and this
was also the case for specific IgG to SEB and TSST-1. This
relationship has also been found in a Japanese study
(Takahashi et al., 2006) and suggests that active immunity
to the toxins is persistent or that low-level exposure to the
antigens is common.
Humans become colonized with S. aureus soon after birth
and some of the highest carriage rates are seen in the first
few months of life (Blackwell et al., 1999; Harrison et al.,
1999a; Peacock et al., 2003; Lindberg et al., 2004). Common
sites of colonization include the upper respiratory tract and
the intestinal tract. Carriage rates decline in infancy but both
sites remain an ecological niche for S. aureus throughout
life. Of the 96 women in this study, 30% were colonized with
S. aureus, 21% had positive nasopharyngeal cultures and
14% had positive stool cultures. These carriage rates are
similar to those demonstrated in previous studies (Peacock
et al., 2003; Harrison et al., 2004; Lindberg et al., 2004). Fifty
per cent of the women had positive nasopharyngeal cultures
on both sampling occasions and 23% had two positive stool
cultures. Thirteen per cent of the isolates produced the toxin
SEB, 13% produced SEC and 24% produced TSST-1. Inter-











































































Fig. 4. Colonization with TSST-1-producing Staphylococcus aureus and
its association with breast milk anti-TSST-1 IgA levels.
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S. aureus isolates from other body sites could explain as to
why between 89% and 97% of the women have antibodies to
one or more of the toxins even though, at any one time,
carriage rates are only 30%.
There was a trend for women colonized with S. aureus
toxin-producing isolates to have greater levels of antitoxin
IgG in cord blood samples compared with women not
colonized with a toxin-producing isolate. This relationship
reached statistical significance (Po 0.05) for SEB.
Levels of passive immunity could be boosted through
breast feeding. Women colonized with isolates producing
TSST-1 had significantly greater levels of breast milk anti-
TSST-1 IgA (Fig. 4, Po 0.01) and the same trend was shown
for SEC/anti-SEC IgA (Po 0.05) and SEB/anti-SEB IgA
(P= 0.078). Gordon et al. (1999) found that two-thirds of
mothers colonized with S. aureus in the nose or throat had
milk samples with levels of IgA to the toxins equal to or
higher than the mean. There is conflicting evidence regard-
ing the role of breast feeding in SIDS (Ford et al., 1993;
Fleming et al., 1996) but some epidemiological studies
report a protective, independent effect (Ford et al., 1993;
Alm et al., 2002).
In conclusion, carriage of a S. aureus toxin-producing
isolate in the later stages of pregnancy triggers the produc-
tion of specific IgG and IgA, which in turn provides
protection for the infant in the first few months of life.
Experimental research is being carried out on the develop-
ment of vaccines that induce IgG to the staphylococcal
pyrogenic toxins (Cui et al., 2005; Hu et al., 2005; Narita
et al., 2008). Vaccination of pregnant women may be
possible in the future and prevent infants being born with
little or no passive immunity to the toxins.
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 AQ: Please check if it should be PBS or PBST.
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
